OTCMKTS:VGWCFValens Groworks Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Valens Groworks Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range$1.31MA: $1.61▼$1.9452-Week Range N/AVolume386,467 shsAverage Volume242,212 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlinesSocial Media Valens Groworks Corp., a biotechnology company, engages in the scientific research of phytopharmaceutical material primarily producing cannabis and cannabis related products. It is also involved in the analytical laboratory testing of cannabis. The company has a collaborative research partnership with UBC Okanagan and Thompson Rivers University. Valens Groworks Corp. is headquartered in Kelowna, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Valens Groworks. Previous Next 2.7 Community Rank Outperform VotesValens Groworks has received 18 “outperform” votes. (Add your “outperform” vote.)Underperform VotesValens Groworks has received 15 “underperform” votes. (Add your “underperform” vote.)Community SentimentValens Groworks has received 54.55% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Valens Groworks and other stocks. Vote “Outperform” if you believe VGWCF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VGWCF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldValens Groworks does not currently pay a dividend.Dividend GrowthValens Groworks does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Valens Groworks insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VGWCF Previous Symbol CUSIPN/A CIKN/A Webwww.valensgroworks.com Phone778-755-0052Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:VGWCF Rates by TradingView Receive VGWCF News and Ratings via Email Sign-up to receive the latest news and ratings for VGWCF and its competitors with MarketBeat's FREE daily newsletter. Valens Groworks (OTCMKTS:VGWCF) Frequently Asked Questions Has Valens Groworks been receiving favorable news coverage? News articles about VGWCF stock have trended positive on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Valens Groworks earned a news impact score of 2.6 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutValens Groworks. Who are some of Valens Groworks' key competitors? Some companies that are related to Valens Groworks include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). View all competitors. Who are Valens Groworks' key executives? Valens Groworks' management team includes the following people: Mr. Andrew Tyler Robson, CEO & DirectorMs. Patricia Ann Storey CPA, CA, BBA, ControllerMr. Christopher Buysen C.A., CPA, CFO & DirectorMr. Everett Knight, Exec. VP of Strategy & InvestmentsMr. Scott Young, VP of Investor Relations & Bus. Devel. What is Valens Groworks' stock symbol? Valens Groworks trades on the OTCMKTS under the ticker symbol "VGWCF." How do I buy shares of Valens Groworks? Shares of VGWCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Valens Groworks' official website? The official website for Valens Groworks is www.valensgroworks.com. How can I contact Valens Groworks? The company can be reached via phone at 778-755-0052. This page was last updated on 6/2/2020 by MarketBeat.com Staff
